<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="editorial">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">CPR</journal-id>
<journal-id journal-id-type="hwp">spcpr</journal-id>
<journal-title>European Journal of Preventive Cardiology</journal-title>
<issn pub-type="ppub">2047-4873</issn>
<issn pub-type="epub">2047-4881</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1741826711421688</article-id>
<article-id pub-id-type="publisher-id">10.1177_1741826711421688</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Methodology</subject>
<subj-group subj-group-type="heading">
<subject>Editorial</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title><italic>P</italic>-values in baseline tables of randomised controlled trials are inappropriate but still common in high impact journals</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Knol</surname><given-names>MJ</given-names></name>
<xref ref-type="corresp" rid="corresp1-1741826711421688"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Groenwold</surname><given-names>RHH</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Grobbee</surname><given-names>DE</given-names></name>
</contrib>
</contrib-group>
<aff id="aff1-1741826711421688">Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, The Netherlands.</aff>
<author-notes>
<corresp id="corresp1-1741826711421688">MJ Knol, UMC Utrecht, Julius Center, PO Box 85500, 3508 GA Utrecht, The Netherlands Email: <email>m.j.knol@umcutrecht.nl</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>4</month>
<year>2012</year>
</pub-date>
<volume>19</volume>
<issue>2</issue>
<fpage>231</fpage>
<lpage>232</lpage>
<permissions>
<copyright-statement>© The European Society of Cardiology 2011 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav</copyright-statement>
<copyright-year>2011</copyright-year>
<copyright-holder content-type="society">European Society of Cardiology</copyright-holder>
</permissions>
</article-meta>
</front>
<body>
<p>Testing for baseline differences between the treatment and control group in randomised controlled trials (RCTs) (see for example a recent article in this journal<sup><xref ref-type="bibr" rid="bibr1-1741826711421688">1</xref></sup>) is not appropriate, as pointed out by numerous papers<sup><xref ref-type="bibr" rid="bibr2-1741826711421688">2</xref>,<xref ref-type="bibr" rid="bibr3-1741826711421688">3</xref></sup> and the CONSORT statement.<sup><xref ref-type="bibr" rid="bibr4-1741826711421688">4</xref></sup> Any baseline differences between the groups under study are by definition due to chance (as long as the randomisation was performed correctly).<sup><xref ref-type="bibr" rid="bibr5-1741826711421688">5</xref></sup> In addition, whether baseline differences are significant does not have any implications for the validity of the results of the study.<sup><xref ref-type="bibr" rid="bibr2-1741826711421688">2</xref>,<xref ref-type="bibr" rid="bibr3-1741826711421688">3</xref></sup> For example, even a covariate that is balanced between treatment groups (according to a <italic>p</italic>-value) can affect the association between treatment and outcome.<sup><xref ref-type="bibr" rid="bibr2-1741826711421688">2</xref></sup> Previous studies reviewed a number of RCTs that were published in 1987 and 1997, and showed that testing for baseline differences was common (58%<sup><xref ref-type="bibr" rid="bibr6-1741826711421688">6</xref></sup> and 48%<sup><xref ref-type="bibr" rid="bibr7-1741826711421688">7</xref></sup>).</p>
<p>We performed a review of all RCTs published in 2008, 2009 or 2010 in major general medical and cardiovascular journals – <italic>Annals of Internal Medicine</italic>, <italic>British Medical Journal</italic> (<italic>BMJ</italic>), <italic>Circulation</italic>, <italic>European Heart Journal</italic>, <italic>Journal of the American Medical Association</italic> (<italic>JAMA</italic>), <italic>Lancet</italic>, <italic>New England Journal of Medicine</italic> (<italic>NEJM</italic>) – to assess how often testing for baseline differences is currently reported. In 388 out of 1115 papers (34.8%) that reported baseline characteristics of the study population, a <italic>p</italic>-value in the baseline table itself or in the footnote accompanying the table was reported (<xref ref-type="table" rid="table1-1741826711421688">Table 1</xref>). There were considerable differences between journals: more than half of the RCTs published in the <italic>JAMA</italic> or <italic>NEJM</italic> reported a <italic>p</italic>-value in their baseline table, whereas this was the case in less than 10% of the RCTs that were published in the <italic>BMJ</italic> or <italic>Lancet</italic>. In the two major cardiovascular journals it was also very common for RCTs to report <italic>p</italic>-values in the baseline table.
<table-wrap id="table1-1741826711421688" position="float"><label>Table 1.</label><caption><p>Total number of RCTs, number of RCTs reporting <italic>p</italic>-values in the baseline table, and number of RCTs without baseline table published in 2008, 2009 or 2010 in major general medical and cardiovascular journals</p></caption>
<graphic alternate-form-of="table1-1741826711421688" xlink:href="10.1177_1741826711421688-table1.tif"/>
<table frame="hsides"><thead align="left">
<tr><th rowspan="2">Journal</th>
<th>Total</th>
<th><italic>p</italic>-value in baseline table</th>
<th>No baseline table</th></tr>
<tr><th>N</th>
<th>N (%)</th>
<th>N</th></tr></thead>
<tbody align="left">
<tr>
<td>JAMA</td>
<td>149</td>
<td>86 (58.5%)</td>
<td>2</td></tr>
<tr>
<td>NEJM</td>
<td>321</td>
<td>169 (54.3%)</td>
<td>10</td></tr>
<tr>
<td>Circulation</td>
<td>141</td>
<td>59 (47.2%)</td>
<td>16</td></tr>
<tr>
<td>European Heart Journal</td>
<td>86</td>
<td>43 (43.9%)</td>
<td>12</td></tr>
<tr>
<td>Annals of Internal Medicine</td>
<td>74</td>
<td>15 (21.1%)</td>
<td>3</td></tr>
<tr>
<td>BMJ</td>
<td>150</td>
<td>11 (7.7%)</td>
<td>7</td></tr>
<tr>
<td>Lancet</td>
<td>254</td>
<td>5 (2.0%)</td>
<td>10</td></tr>
<tr>
<td>Total</td>
<td>1175</td>
<td>388 (34.8%)</td>
<td>60</td></tr>
</tbody>
</table>
</table-wrap></p>
<p>Even though the proportion of papers on RCTs that report <italic>p</italic>-values in the baseline table seemed to have decreased over the last two decades, when comparing previous reviews<sup><xref ref-type="bibr" rid="bibr6-1741826711421688">6</xref>,<xref ref-type="bibr" rid="bibr7-1741826711421688">7</xref></sup> with our data, it is still very common in some of the major medical and cardiovascular journals. This is even more remarkable as all these journals ask their authors to adhere to the CONSORT statement, which states that statistical tests on baseline characteristics should not be performed in RCTs.<sup><xref ref-type="bibr" rid="bibr4-1741826711421688">4</xref></sup> Researchers and editors alike should change this common but erroneous practice.</p>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="bibr1-1741826711421688"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Davidson</surname><given-names>PM</given-names></name><name><surname>Cockburn</surname><given-names>J</given-names></name><name><surname>Newton</surname><given-names>PJ</given-names></name><name><surname>Webster</surname><given-names>JK</given-names></name><name><surname>Betihavas</surname><given-names>V</given-names></name><name><surname>Howes</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Can a heart failure-specific cardiac rehabilitation program decrease hospitalizations and improve outcomes in high-risk patients?</article-title>. <source>Eur J Cardiovasc Prev Rehabil</source> <year>2010</year>; <volume>17</volume>: <fpage>393</fpage>–<lpage>402</lpage>.</citation></ref>
<ref id="bibr2-1741826711421688"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Senn</surname><given-names>S</given-names></name></person-group>. <article-title>Testing for baseline balance in clinical trials</article-title>. <source>Stat Med</source> <year>1994</year>; <volume>13</volume>: <fpage>1715</fpage>–<lpage>1726</lpage>.</citation></ref>
<ref id="bibr3-1741826711421688"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>C</given-names></name><name><surname>Torgerson</surname><given-names>DJ</given-names></name></person-group>. <article-title>Understanding controlled trials: baseline imbalance in randomised controlled trials</article-title>. <source>BMJ</source> <year>1999</year>; <volume>319</volume>: <fpage>185</fpage>–<lpage>185</lpage>.</citation></ref>
<ref id="bibr4-1741826711421688"><label>4</label><citation citation-type="web"><comment><ext-link ext-link-type="uri" xlink:href="http://www.consort-statement.org/consort-statement/13-19-results/item15_baseline-data/">http://www.consort-statement.org/consort-statement/13-19—results/item15_baseline-data/</ext-link>. (accessed August 2011)</comment>.</citation></ref>
<ref id="bibr5-1741826711421688"><label>5</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Grobbee</surname><given-names>DE</given-names></name><name><surname>Hoes</surname><given-names>AW</given-names></name></person-group>. <article-title>Randomized trials</article-title>. <source>Clinical epidemiology</source>. <publisher-loc>Sudbury, MA</publisher-loc>: <publisher-name>Jones and Bartlett Publishers</publisher-name>, <year>2009</year>, pp. <fpage>270</fpage>–<lpage>287</lpage>.</citation></ref>
<ref id="bibr6-1741826711421688"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Altman</surname><given-names>DG</given-names></name><name><surname>Dore</surname><given-names>CJ</given-names></name></person-group>. <article-title>Randomisation and baseline comparisons in clinical trials</article-title>. <source>Lancet</source> <year>1990</year>; <volume>335</volume>: <fpage>149</fpage>–<lpage>153</lpage>.</citation></ref>
<ref id="bibr7-1741826711421688"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Assmann</surname><given-names>SF</given-names></name><name><surname>Pocock</surname><given-names>SJ</given-names></name><name><surname>Enos</surname><given-names>LE</given-names></name><name><surname>Kasten</surname><given-names>LE</given-names></name></person-group>. <article-title>Subgroup analysis and other (mis)uses of baseline data in clinical trials</article-title>. <source>Lancet</source> <year>2000</year>; <volume>355</volume>: <fpage>1064</fpage>–<lpage>1069</lpage>.</citation></ref>
</ref-list>
</back>
</article>